Cardlytics Proceeds Income Contraction Among Deterioration Economics (NASDAQ: CDLX)

.Financial writer advises selling Cardlytics, Inc. due to decreasing system business economics, earnings challenges, as well as damaging economic trends. Click on for this CDLX improve.